missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human SFT2D2 (aa 1-33) Control Fragment Recombinant Protein
Description
Highest antigen sequence indentity to the following orthologs: Mouse (97%), Rat (97%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-59914 (PA5-59914. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
May be involved in fusion of retrograde transport vesicles derived from an endocytic compartment with the Golgi complex.
Specifications
Specifications
| Accession Number | O95562 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 375035 |
| Name | Human SFT2D2 (aa 1-33) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 2010005O13Rik; AI506168; AW561909; cI-45; dJ747L4.C1.2; RGD1310623; SFT2 domain containing 2; SFT2 domain-containing protein 2; SFT2D2; sft2d2 {ECO:0000250; UniProtKB:O95562}; UNQ512; UNQ512/PRO1027; Vesicle transport protein SFT2B |
| Common Name | SFT2D2 |
| Show More |